oncology

Sanofi strikes deal for Emcure to market oncology portfolio in India
First Word Pharma
Wed, 08/6/14 - 08:07 am
Sanofi
Emcure
India
oncology
Pfizer: Struggling Through A Tough Time
Seeking Alpha
Wed, 07/16/14 - 08:58 am
Pfizer
China
Viagra
patents
Cellectis
oncology
GlaxoSmithKline Is Moving Forward After Woeful Performance
Seeking Alpha
Tue, 07/8/14 - 05:40 pm
GSK
vaccines
oncology
Novartis
Anoro Ellipta
The Sirens of Ziopharm
Seeking Alpha
Mon, 06/16/14 - 07:37 am
sarcoma
oncology
Ziopharm
Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave
Fierce Pharma Marketing
Thu, 05/8/14 - 12:30 pm
oncology
JNJ
Roche
Celgene
Zytiga
Kadcyla
Nexavar
Gleevec
Best Weapon In The War On Cancer? Data Sharing
Forbes
Fri, 04/25/14 - 08:18 am
data sharing
clinical trials
cancer
oncology
Project Data Sphere
Illumina Expands Product Portfolio to Support Oncology Clinical Research and Discovery
Yahoo
Wed, 04/2/14 - 07:31 am
Illumina
oncology
drug discovery
next-generation gene sequencing
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
Seeking Alpha
Mon, 02/24/14 - 09:19 am
Ignyta
oncology
Clovis Oncology
Ariad Pharmaceuticals
Mirati Therapeutics
Tesaro
Puma Biotechnology
Oncology, Streamlined R&D Will Help Pfizer Going Forward
Forbes
Thu, 02/20/14 - 09:31 am
R&D
Pfizer
oncology
Poor Pipeline Management Imperils Lilly's Future Cash Flows
Motley Fool
Mon, 02/17/14 - 03:22 pm
Eli Lilly
diabetes
insulin
Novo Nordisk
Sanofi
oncology
Alzheimer's disease
Merck & Co., Inc. Pushing The Throttle On Oncology
Motley Fool
Fri, 02/7/14 - 10:29 am
Merck
oncology
cancer
MK-3475
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
Seeking Alpha
Fri, 01/31/14 - 08:14 am
oncology
immunotherapy
Bristol-Myers Squibb
melanoma
Yervoy
The Bristol-Myers Squibb Co. Overreaction Highlights The Dependence On Oncology
Motley Fool
Wed, 01/29/14 - 09:32 am
oncology
Bristol-Myers Squibb
What You Need to Know About Amgen's Oncology Line-Up
Motley Fool
Thu, 01/23/14 - 09:52 am
Amgen
oncology
T-Vec
Kyprolis
Amgen spinoff Atara cranks its Series B up to $52M
Fierce Biotech
Fri, 01/10/14 - 06:58 pm
Amgen
Atara
Series B
oncology
kidney disease
Zymeworks pockets $15M, woos Lilly with its double-barreled antibodies
Fierce Biotech
Fri, 01/10/14 - 08:34 am
Zymeworks
oncology
Eli Lilly
Canada
antibodies
Rexahn: A Turn Around Story For 2014
Seeking Alpha
Mon, 12/23/13 - 09:59 am
Rexahn
oncology
Pfizer’s Schulman to Leave as Head of New Drug Unit
Bloomberg
Tue, 12/17/13 - 10:39 am
Pfizer
Amy Schulman
consumer health
vaccines
oncology
Does Sanofi Need to Turn to M&A to Bulk Up Its Oncology Assets?
Motley Fool
Tue, 12/3/13 - 11:35 am
M&A
Sanofi
oncology
Celgene
Clovis Oncology
Seattle Genetics
Drug developer Compugen sees boost from Bayer oncology deal
Yahoo/Reuters
Mon, 11/25/13 - 10:41 am
Bayer
CompuGen
oncology

Pages